Tag: growth pharma
November 25, 2018
What is In-licensing?
In-licensing may be pharma’s preferred mode of business development these days. Should that impact your investment strategy? March 27, 2017
Allergan and Paratek Show Positive Results For Acne Treatment
Allergan (NYSE:AGN) and Paratek Pharmaceuticals (NASDAQ:PRTK) announced successful initial results for the two and Phase 3 trials of their acne...
December 26, 2016
Top Pharmaceutical News Stories of 2016
2016 saw countless pharmaceutical companies taken to task for price gouging. Close to the end of the year, a related... December 20, 2016
Allergan to Acquire Acelity L.P. Inc.'s LifeCell Corporation for $2.9 Billion
Allergan, a leading global biopharmaceutical company, and Acelity today announced that they have entered into a definitive agreement under which... November 16, 2016
Allergan Announces Partnership with Amy Dixon, Elite Paratriathlete
Allergan today announced a national partnership with Amy Dixon, world champion paratriathlete and irritable bowel syndrome with diarrhea (IBS-D) patient.
October 4, 2016
Another Acquisition for Allergan Makes Six Since August
Six acquisitions indicate Allergan’s refined strategic focus, as well as CEO Brent Saunders’ continued commitment to a “growth pharma” business... October 3, 2016